drugset / Trial / NCT04050163
MiSaver® Stem Cell Treatment for Heart Attack (Acute Myocardial Infarction)
Non-randomizedSequentialSingle-blindTreatment
Summary
The objective of the present study is to establish the safety and efficacy of MiSaver® Stem Cell Treatment After a Heart Attack (Acute Myocardial Infarction)
Timeline
- Start
- 2021-01-26
- Primary completion
- 2023-05-04
- Completion
- 2023-05-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rexlemestrocel-L | Cell therapy | 0.5 cells/kg | Intravenous |
| Subject | Rexlemestrocel-L | Cell therapy | 1.6 cells/kg | Intravenous |
| Subject | Rexlemestrocel-L | Cell therapy | 5 cells/kg | Intravenous |